Your browser doesn't support javascript.
loading
Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.
Nichols, Hazel B; Schoemaker, Minouk J; Cai, Jianwen; Xu, Jiawei; Wright, Lauren B; Brook, Mark N; Jones, Michael E; Adami, Hans-Olov; Baglietto, Laura; Bertrand, Kimberly A; Blot, William J; Boutron-Ruault, Marie-Christine; Dorronsoro, Miren; Dossus, Laure; Eliassen, A Heather; Giles, Graham G; Gram, Inger T; Hankinson, Susan E; Hoffman-Bolton, Judy; Kaaks, Rudolf; Key, Timothy J; Kitahara, Cari M; Larsson, Susanna C; Linet, Martha; Merritt, Melissa A; Milne, Roger L; Pala, Valeria; Palmer, Julie R; Peeters, Petra H; Riboli, Elio; Sund, Malin; Tamimi, Rulla M; Tjønneland, Anne; Trichopoulou, Antonia; Ursin, Giske; Vatten, Lars; Visvanathan, Kala; Weiderpass, Elisabete; Wolk, Alicja; Zheng, Wei; Weinberg, Clarice R; Swerdlow, Anthony J; Sandler, Dale P.
Afiliação
  • Nichols HB; University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina (H.B.N., J.C., J.X.).
  • Schoemaker MJ; The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.).
  • Cai J; University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina (H.B.N., J.C., J.X.).
  • Xu J; University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina (H.B.N., J.C., J.X.).
  • Wright LB; The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.).
  • Brook MN; The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.).
  • Jones ME; The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.).
  • Adami HO; Karolinska Institutet, Stockholm, Sweden (H.A.).
  • Baglietto L; University of Pisa, Pisa, Italy (L.B.).
  • Bertrand KA; Slone Epidemiology Center at Boston University, Boston, Massachusetts (K.A.B., J.R.P.).
  • Blot WJ; Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, Tennessee (W.J.B., W.Z.).
  • Boutron-Ruault MC; Institut National de la Santé et de la Recherche Médicale (INSERM) U1018 and Institut Gustave Roussy Centre for Research in Epidemiology and Population Health, Villejuif, France (M.B.).
  • Dorronsoro M; Public Health Direction and Biodonostia Research Institute and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Basque Regional Health Department, San Sebastian, Spain (M.D.).
  • Dossus L; International Agency for Research on Cancer, Lyon, France (L.D.).
  • Eliassen AH; Brigham and Women's Hospital, Harvard Medical School, and Harvard T.H. Chan School of Public Health, Boston, Massachusetts (A.H.E., R.M.T.).
  • Giles GG; Cancer Council Victoria and University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia (G.G.G., R.L.M.).
  • Gram IT; University of Tromsø, The Arctic University of Norway, Tromsø, Norway (I.T.G.).
  • Hankinson SE; University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, Massachusetts (S.E.H.).
  • Hoffman-Bolton J; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (J.H.).
  • Kaaks R; German Cancer Research Center, Heidelberg, Germany (R.K.).
  • Key TJ; University of Oxford, Oxford, United Kingdom (T.J.K.).
  • Kitahara CM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.M.K., M.L.).
  • Larsson SC; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.C.L., A.W.).
  • Linet M; National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.M.K., M.L.).
  • Merritt MA; School of Public Health, Imperial College London, London, United Kingdom (M.A.M., E.R.).
  • Milne RL; Cancer Council Victoria and University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia (G.G.G., R.L.M.).
  • Pala V; Cancer Registry of Norway, Institute of Population-Based Cancer Research, and University of Oslo, Oslo, Norway, and University of Southern California, Los Angeles, California (V.P.).
  • Palmer JR; Slone Epidemiology Center at Boston University, Boston, Massachusetts (K.A.B., J.R.P.).
  • Peeters PH; University Medical Center Utrecht, Utrecht, the Netherlands (P.H.P.).
  • Riboli E; School of Public Health, Imperial College London, London, United Kingdom (M.A.M., E.R.).
  • Sund M; Umeå University, Umeå, Sweden (M.S.).
  • Tamimi RM; Brigham and Women's Hospital, Harvard Medical School, and Harvard T.H. Chan School of Public Health, Boston, Massachusetts (A.H.E., R.M.T.).
  • Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark (A.T.).
  • Trichopoulou A; Hellenic Health Foundation, Athens, Greece (A.T.).
  • Ursin G; Norwegian University of Science and Technology, Trondheim, Norway (G.U., L.V.).
  • Vatten L; Norwegian University of Science and Technology, Trondheim, Norway (G.U., L.V.).
  • Visvanathan K; Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, Baltimore, Maryland (K.V.).
  • Weiderpass E; Karolinska Institutet, Stockholm, Sweden, University of Tromsø, The Arctic University of Norway, Tromsø, Norway, and Folkhälsan Research Center, Helsinki, Finland (E.W.).
  • Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.C.L., A.W.).
  • Zheng W; Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, Tennessee (W.J.B., W.Z.).
  • Weinberg CR; National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina (C.R.W., D.P.S.).
  • Swerdlow AJ; The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.).
  • Sandler DP; National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina (C.R.W., D.P.S.).
Ann Intern Med ; 170(1): 22-30, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30534999
ABSTRACT

Background:

Parity is widely recognized as protective for breast cancer, but breast cancer risk may be increased shortly after childbirth. Whether this risk varies with breastfeeding, family history of breast cancer, or specific tumor subtype has rarely been evaluated.

Objective:

To characterize breast cancer risk in relation to recent childbirth.

Design:

Pooled analysis of individual-level data from 15 prospective cohort studies.

Setting:

The international Premenopausal Breast Cancer Collaborative Group.

Participants:

Women younger than 55 years. Measurements During 9.6 million person-years of follow-up, 18 826 incident cases of breast cancer were diagnosed. Hazard ratios (HRs) and 95% CIs for breast cancer were calculated using Cox proportional hazards regression.

Results:

Compared with nulliparous women, parous women had an HR for breast cancer that peaked about 5 years after birth (HR, 1.80 [95% CI, 1.63 to 1.99]) before decreasing to 0.77 (CI, 0.67 to 0.88) after 34 years. The association crossed over from positive to negative about 24 years after birth. The overall pattern was driven by estrogen receptor (ER)-positive breast cancer; no crossover was seen for ER-negative cancer. Increases in breast cancer risk after childbirth were pronounced when combined with a family history of breast cancer and were greater for women who were older at first birth or who had more births. Breastfeeding did not modify overall risk patterns.

Limitations:

Breast cancer diagnoses during pregnancy were not uniformly distinguishable from early postpartum diagnoses. Data on human epidermal growth factor receptor 2 (HER2) oncogene overexpression were limited.

Conclusion:

Compared with nulliparous women, parous women have an increased risk for breast cancer for more than 20 years after childbirth. Health care providers should consider recent childbirth a risk factor for breast cancer in young women. Primary Funding Source The Avon Foundation, the National Institute of Environmental Health Sciences, Breast Cancer Now and the UK National Health Service, and the Institute of Cancer Research.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Parto Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Parto Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Ano de publicação: 2019 Tipo de documento: Article